A Strategy to End AIDS
If you are HIV-negative but worry about becoming HIV-positive
PrEP could be right for you
Pre-Exposure Prophylaxis (PrEP) is a medication for HIV-negative individuals to reduce their risk of becoming infected with HIV. The FDA approved Truvada, a tablet taken orally once daily, to reduce the chance of HIV infection after unprotected sex and other risky behavior. PrEP blocks infection by preventing HIV replication, and is most effective when taken daily.
There has been an increased push recently to provide PrEP to high risk individuals due to increasing evidence of effectiveness, strong support from HIV/AIDS organizations, and Governor Cuomo’s plan to “bend the curve,” in which he calls for providing access to PrEP for individuals at high risk for HIV infection.
Recent clinical trials provide evidence for the efficacy of PrEP. In the population that took the PrEP medication regularly, PrEP decreased HIV incidence by 92%.
Before being prescribed PrEP, individuals will need to have an honest conversation with a health care provider to assess if they are a good candidate for PrEP; how often they will need to be tested for HIV and other STDs; and if there are ways to help them pay for PrEP if they need assistance.